深圳市新产业生物医学工程股份有限公司 投资者关系活动记录表 | | □特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 □业绩说明会 | | 投资者关系 | □新闻发布会 □路演活动 | | 活动类别 | ☑现场参观 | | | 线上交流、华创证券策略会、中信建投证券策略会、国 ☑其他 | | | 盛证券策略会 | | 参与单位名 | | | 称及人员姓 | 共计 10 家机构，12 名参会人员，详见附件《与会机构名单》 | | 名 | | | 时间 | 2025 年 7 月 2 日-7 月 24 日 | | 地点 | 深圳市坪山区坑梓街道金沙社区锦绣东路 23 号新产业生物大厦 | | | 等； | | 上市公司接 | 副总经理兼董事会秘书 张蕾 | | 待人员姓名 | 投资者关系负责人 吕宇宁 | | 投资者关系 | | | 活动主要内 | 除前期已披露的投资者关系活动交流内容外，无新增主要互 | | 容介绍 | 动交流内容。 | | 附件清单 | 详见附件《与会机构名单》 | 1 深圳市新产业生物医学工程股份有限公司 投资者关系活动记录表 证券代码：300832 证券简称： ...

Core Insights - The forum focused on the strategic significance of brain-computer interface (BCI) technology in future technological development and industrial transformation [1] - Nearly a hundred experts and scholars from various fields participated, discussing the latest research and clinical applications of BCI technology [1] Group 1: Forum Overview - The 27th China Association for Science and Technology Annual Conference featured a specialized forum on brain-computer interfaces and intelligent innovation [1] - The forum was hosted by the China Association for Science and Technology and organized by the Chinese Rehabilitation Medicine Association [1] Group 2: Key Presentations - Zhao Jizong from the Chinese Academy of Sciences presented on clinical experimental research related to BCIs [3] - Yan Tianyi from Beijing Institute of Technology discussed non-invasive neural modulation technologies and their applications [5] - Liu Hesheng, Chief Scientist at Changping Laboratory, reported on brain function localization and regulation [5] - Chen Xun from the University of Science and Technology of China presented on multi-source neural signal computation [7] - He Huiguang from the Chinese Academy of Automation discussed visual restoration and reconstruction based on BCIs [7] - Shan Chunlei, Dean of the Rehabilitation Research Institute at Shanghai Jiao Tong University, shared insights on the empowerment of functional rehabilitation through BCIs [9] - Li Yuanqing from South China University of Technology highlighted BCIs as a frontier technology benefiting humanity [9] - Wu Wen from Southern Medical University discussed the application of BCI technology in motor rehabilitation [11] Group 3: Expert Discussions - Following the main presentations, experts engaged in discussions on topics such as the accuracy of neural signal encoding and decoding, the development of invasive and non-invasive BCIs, and the standardization of BCI technology [20] - The discussions also covered the exploration of talent cultivation models for BCI technology [20]

Core Insights - The article discusses a recent event at Tsinghua University where a team utilized non-invasive brain-computer interface technology in aesthetic and artistic research, marking a significant advancement in the field of neuroaesthetics [4][6]. Group 1: Neuroaesthetics Research - The Tsinghua University Neuroengineering Laboratory's research team aims to decode audience aesthetic experiences by synchronously capturing neural activity during live performances [4][6]. - Neuroaesthetics is an emerging interdisciplinary field that combines neuroscience with art and humanities, focusing on how humans perceive and evaluate beauty at a neural level [5]. - The research utilizes non-invasive brainwave caps to collect data from multiple participants simultaneously, enhancing the understanding of audience engagement in real-time artistic experiences [6][8]. Group 2: Technological Advancements - China's research in non-invasive brain-computer interface technology has been ongoing since the 1990s, with the country now being on par with international counterparts and even leading in certain aspects [6]. - The application of non-invasive brain-computer interfaces in rehabilitation has shown significant results, with recovery times reduced by one-third and effectiveness improved by one-third compared to traditional methods [6]. - The current experiment represents the first systematic application of non-invasive brain-computer interface technology in neuroaesthetics research, providing high temporal resolution and the ability to operate in natural settings [6][8]. Group 3: Future Directions - Future plans include exploring the mechanisms behind core aesthetic experiences such as "immersion" and "empathy," and applying findings to support artistic creation, emotional regulation, and rehabilitation [13].

Core Insights - The article emphasizes the importance of biomanufacturing as a new industry that leverages biological functions for large-scale material processing and transformation, contributing to industrial goods for societal development [1] - Hubei province aims to advance technological and industrial innovation by balancing the transformation of traditional industries with the cultivation of emerging and future industries [1] Group 1: Biomanufacturing Development in Hubei - Hubei has a solid foundation for developing biomanufacturing, supported by its strong biological industry and innovation capabilities [2] - The province has 11.5 million biopharmaceutical companies and 36,452 biopharmaceutical patents, with Wuhan housing 42,080 biopharmaceutical companies and 19,791 patents [2] - Biomanufacturing is seen as a new growth point for Hubei's biological industry, creating new materials and ensuring sustainable production methods [2][3] Group 2: Educational and Research Initiatives - Hubei University is focusing on enhancing its capabilities in synthetic biology and biomanufacturing to support the province's industrial layout [3] - The university is investing in talent, platforms, and research to address the bottlenecks in industrial transformation and to develop core technologies in biomanufacturing [3][5] - Hubei University has established a synthetic biology innovation consortium with leading enterprises to drive the development of biomanufacturing in the region [3] Group 3: Strategic Planning and Integration - Hubei's future biomanufacturing development should align with China's modernization goals, focusing on economic and social benefits [4] - The province plans to create a 5-10 year development plan for biomanufacturing, emphasizing foundational biotechnology upgrades and high-value biological product development [4][5] - The strategy includes attracting leading companies in the biomanufacturing sector to enhance resource integration and support the growth of related academic disciplines [5]